BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8827071)

  • 1. Pax-2, kidney development, and oncogenesis.
    Dressler GR
    Med Pediatr Oncol; 1996 Nov; 27(5):440-4. PubMed ID: 8827071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factors in renal development: the WT1 and Pax-2 story.
    Dressler GR
    Semin Nephrol; 1995 Jul; 15(4):263-71. PubMed ID: 7569406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific regulation of the WT1 locus.
    Hewitt JA; Kessler PM; Campbell CE; Williams BR
    Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
    Mrowka C; Schedl A
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
    Eccles MR; Yun K; Reeve AE; Fidler AE
    Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of WT1.
    Haber DA; Englert C; Maheswaran S
    Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pax2 in development and renal disease.
    Dressler GR; Woolf AS
    Int J Dev Biol; 1999; 43(5):463-8. PubMed ID: 10535325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
    Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities.
    Dressler GR; Wilkinson JE; Rothenpieler UW; Patterson LT; Williams-Simons L; Westphal H
    Nature; 1993 Mar; 362(6415):65-7. PubMed ID: 8383297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
    Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
    Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.